Cooperative Agreement NU62PS924879
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $499,671 Cooperative Agreement to the Pennsylvania Department of Health (PADOH) under the HIV Prevention Activities Health Department Based (CFDA 93.940) federal grant program. The 5-year award, effective September 30, 2025 through September 29, 2030, supports PADOH's comprehensive efforts to prevent, control, and ultimately eliminate HIV and tuberculosis (TB) in Pennsylvania. Key activities under this Cooperative Agreement...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $874,378 Cooperative Agreement to the County of Los Angeles Department of Public Health (DPH) on September 30, 2025 under the HIV Prevention Activities Health Department Based (CFDA 93.940) Federal Grant Program. This funding supports DPH's comprehensive efforts to prevent, control, and eliminate HIV and tuberculosis (TB) through targeted testing, treatment, contact investigation, and community engagement strategies. The award...
- The Centers for Disease Control and Prevention (CDC) awarded a $731,845 Cooperative Agreement under the HIV Prevention Activities Health Department Based program (CFDA 93.940) to the City of Houston Department of Health and Human Services. The award, which began on September 30, 2025 and will continue through September 29, 2030, supports the city's efforts to establish and maintain comprehensive HIV prevention and surveillance programs. The funding will enable the City of Houston to implement...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $930,841 Cooperative Agreement to the Department of Public Health Illinois on September 30, 2025 under the HIV Prevention Activities Health Department Based (CFDA 93.940) federal grant program. This five-year award supports comprehensive efforts by the state health department to prevent, control, and eliminate HIV and tuberculosis, with a focus on reducing transmission, identifying and treating active and latent infections,...
- This $1,034,315 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under CFDA 93.940 "HIV Prevention and Surveillance Activities-Health Department Based" supports comprehensive efforts by the Florida Department of Health (FDOH) to prevent, control, and eliminate HIV and tuberculosis (TB) in the state. The grant funds a 5-year project (Sep 2025 - Sep 2030) where the FDOH will implement targeted testing, treatment, contact investigation, and community...
- The City and County of San Francisco's Public Health Department was awarded a $643,882 Cooperative Agreement by the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based (CFDA 93.940) federal grant program. The award, effective September 30, 2025 through September 29, 2030, supports the Medical Monitoring Project (MMP), a key HIV surveillance activity that describes the behavioral and clinical characteristics of people with HIV (PWH) in...
- The Philadelphia Department of Public Health (PDPH) was awarded a $2,319,564 Cooperative Agreement from the Centers for Disease Control and Prevention's (CDC) National Center for Immunization and Respiratory Diseases under the Grants to States for Medicaid (CFDA 93.778) program. The five-year award, running from July 1, 2025 to June 30, 2030, will fund the PDPH Immunization Program's efforts to strengthen vaccine-preventable disease prevention and response in Philadelphia. Key strategies...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $489,198 Cooperative Agreement to the Mississippi State Department of Health (MSDH) Finance & Accounts Division on September 30, 2025 under the HIV Prevention Activities Health Department Based (CFDA 93.940) Federal Grant Program. This program provides funding to state, local, and territorial health departments to establish and maintain HIV prevention and surveillance programs, with a focus on reducing HIV transmission,...
- This federal Cooperative Agreement award, in the amount of $735,652.00, was granted on September 30, 2025 by the National Center for HIV/AIDS, a civilian federal agency. The award supports the HIV Prevention Activities Health Department Based (CFDA 93.940) program, which provides funding to state and local health departments to establish and maintain comprehensive HIV prevention and surveillance programs. The Department of State Health Services in Texas will use the award to implement targeted...
- The Philadelphia Department of Public Health (PDPH) was awarded a $4,018,665 Cooperative Agreement for Emergency Response: Public Health Crisis Response (CFDA 93.354) from the U.S. Centers for Disease Control and Prevention (CDC). This funding will allow PDPH to bolster its capacity to respond to public health emergencies, such as the COVID-19 pandemic, by hiring additional personnel to conduct response functions, procuring personal protective equipment and other critical supplies, and...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $579,853 Cooperative Agreement under the HIV Prevention Activities Health Department Based (CFDA 93.940) program to the Philadelphia Department of Public Health (PDPH) effective September 30, 2025. This 5-year award supports PDPH's comprehensive efforts to prevent, control, and eliminate HIV and tuberculosis (TB) in the Philadelphia metropolitan area. Through this funding, PDPH will implement targeted testing, treatment, contact investigation, and community engagement strategies to reduce HIV transmission, identify and treat active/latent TB infections, and address health disparities among high-risk populations including men who have sex with men, people who inject drugs, and transgender individuals. Key activities include diagnosing undiagnosed HIV cases, rapidly linking individuals to care, supporting viral suppression, and preventing new infections through interventions like pre-exposure prophylaxis (PrEP), condom promotion, and syringe service programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $579.9k | 9/29/25 |